Sri Venkateshwaraa Medical College Hospital and Research Centre, Pondicherry, 605102, India.
Calcutta Institute of Pharmaceutical Technology and Allied Health Sciences, Howrah, WB, 711316, India.
Med Oncol. 2022 Jan 4;39(2):20. doi: 10.1007/s12032-021-01615-6.
As per World Health Organization cancer remains as a leading killer disease causing nearly 10 million deaths in 2020. Since the burden of cancer increases worldwide, warranting an urgent search for anti-cancer compounds from natural sources. Secondary metabolites from plants, marine organisms exhibit a novel chemical and structural diversity holding a great promise as therapeutics in cancer treatment. These natural metabolites target only the cancer cells and the normal healthy cells are left unharmed. In the emerging trends of cancer treatment, the natural bioactive compounds have long become a part of cancer chemotherapy. In this review, we have tried to compile about eight bioactive compounds from plant origin viz. combretastatin, ginsenoside, lycopene, quercetin, resveratrol, silymarin, sulforaphane and withaferin A, four marine-derived compounds viz. bryostatins, dolastatins, eribulin, plitidepsin and three microorganisms viz. Clostridium, Mycobacterium bovis and Streptococcus pyogenes with their well-established anticancer potential, mechanism of action and clinical establishments are presented.
根据世界卫生组织的数据,癌症仍然是导致 2020 年近 1000 万人死亡的主要杀手疾病。由于癌症负担在全球范围内增加,因此迫切需要从天然来源中寻找抗癌化合物。植物、海洋生物的次生代谢产物表现出新颖的化学和结构多样性,作为癌症治疗的疗法具有很大的潜力。这些天然代谢物仅针对癌细胞,正常健康细胞不受伤害。在癌症治疗的新兴趋势中,天然生物活性化合物早已成为癌症化疗的一部分。在这篇综述中,我们试图从植物来源中编译了 8 种生物活性化合物,包括 combretastatin、ginsenoside、lycopene、quercetin、resveratrol、silymarin、sulforaphane 和 withaferin A,4 种海洋衍生化合物,包括 bryostatins、dolastatins、eribulin、plitidepsin 和 3 种微生物,包括 Clostridium、Mycobacterium bovis 和 Streptococcus pyogenes,它们具有良好的抗癌潜力、作用机制和临床应用。